BIOHARVEST SCIENCES INC.
For the period ended Dec 31, 2024. Filed Mar 31, 2025.
View on SEC.govAbout this filing
The yearly report of certain Canadian companies, filed under a joint US and Canadian system. It is the main yearly account these companies give US investors, largely as filed in Canada.
FY2024 · Filed Mar 31, 2025
Use the contents to explore the available documents and sections.
BHST$1.59+6.7%Stored close · as of Nov 6, 2026
Contents
EX-99.2 · Segment information
Segment information
| For the year ended December 31, 2024 | |||
|---|---|---|---|
| Products | CDMO Services | Total | |
| Revenues | 24,906 | 282 | 25,188 |
| Cost of revenues | 11,061 | 185 | 11,246 |
| Segment loss | 5,797 | 1,192 | 6,989 |
| Finance expense, net | 5,916 | ||
| Tax expenses | 8 | ||
| Net loss and comprehensive loss | 12,913 | ||
| For the year ended December 31, 2023 | |||
|---|---|---|---|
| Products | CDMO Services | Total | |
| Revenues | 12,672 | - | 12,672 |
| Cost of revenues | 7,039 | - | 7,039 |
| Segment loss | 9,966 | - | 9,966 |
| Finance expense, net | 2,598 | ||
| Tax expenses | - | ||
| Net loss and comprehensive loss | 12,564 | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.